Format
Items per page
Sort by

Send to:

Choose Destination

Results: 11

1.

Lipoprotein-associated phospholipase A(2) and atherosclerosis.

Wilensky RL, Macphee CH.

Curr Opin Lipidol. 2009 Oct;20(5):415-20. doi: 10.1097/MOL.0b013e3283307c16. Review.

PMID:
19667981
[PubMed - indexed for MEDLINE]
2.

Crystal structure of human plasma platelet-activating factor acetylhydrolase: structural implication to lipoprotein binding and catalysis.

Samanta U, Bahnson BJ.

J Biol Chem. 2008 Nov 14;283(46):31617-24. doi: 10.1074/jbc.M804750200. Epub 2008 Sep 10.

PMID:
18784071
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention.

Anderson JL.

Am J Cardiol. 2008 Jun 16;101(12A):23F-33F. doi: 10.1016/j.amjcard.2008.04.015. Review.

PMID:
18549868
[PubMed - indexed for MEDLINE]
4.

Plasma PAF-acetylhydrolase: an unfulfilled promise?

Karabina SA, Ninio E.

Biochim Biophys Acta. 2006 Nov;1761(11):1351-8. Epub 2006 May 23. Review.

PMID:
16807087
[PubMed - indexed for MEDLINE]
5.

Oxidized phospholipids as triggers of inflammation in atherosclerosis.

Leitinger N.

Mol Nutr Food Res. 2005 Nov;49(11):1063-71. Review.

PMID:
16270279
[PubMed - indexed for MEDLINE]
6.

Clinical review: Lipoprotein-associated phospholipase A2, a novel inflammatory biomarker and independent risk predictor for cardiovascular disease.

Sudhir K.

J Clin Endocrinol Metab. 2005 May;90(5):3100-5. Epub 2005 Feb 15. Review.

PMID:
15713711
[PubMed - indexed for MEDLINE]
7.

The identification of clinical candidate SB-480848: a potent inhibitor of lipoprotein-associated phospholipase A2.

Blackie JA, Bloomer JC, Brown MJ, Cheng HY, Hammond B, Hickey DM, Ife RJ, Leach CA, Lewis VA, Macphee CH, Milliner KJ, Moores KE, Pinto IL, Smith SA, Stansfield IG, Stanway SJ, Taylor MA, Theobald CJ.

Bioorg Med Chem Lett. 2003 Mar 24;13(6):1067-70.

PMID:
12643913
[PubMed - indexed for MEDLINE]
8.

Plasma platelet activating factor-acetylhydrolase (PAF-AH).

Karasawa K, Harada A, Satoh N, Inoue K, Setaka M.

Prog Lipid Res. 2003 Mar;42(2):93-114. Review.

PMID:
12547653
[PubMed - indexed for MEDLINE]
9.

The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis.

Zimmerman GA, McIntyre TM, Prescott SM, Stafforini DM.

Crit Care Med. 2002 May;30(5 Suppl):S294-301. Review.

PMID:
12004251
[PubMed - indexed for MEDLINE]
10.

A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid).

Blank ML, Lee T, Fitzgerald V, Snyder F.

J Biol Chem. 1981 Jan 10;256(1):175-8.

PMID:
7451433
[PubMed - indexed for MEDLINE]
Free Article
11.

Preliminary studies of an acid-labile factor (ALF) in human sera that inactivates platelet-activating factor (PAF).

Farr RS, Cox CP, Wardlow ML, Jorgensen R.

Clin Immunol Immunopathol. 1980 Mar;15(3):318-330. No abstract available.

PMID:
7371225
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk